OLD: Cafepharma Detail Piece Daily Pharma Headlines Archive for February, 2012

IMPORTANT: On Sunday, April 22, we send out an email with some important changes to our newsletter service. Please make sure you read this email, or the details on our our newsletter page, as our newsletter service changes will be taking effect on Monday, May 7, 2018.  On that date, your current newsletter subscription will end if you have not subscribed under our new plan. 

Click a link below to view the mailing archive as if it had been sent to you. 2012-02-29 12:00 Will FDA Delay Approving The Eliquis Bloodthinner? and more... 2012-02-29 00:00 Merck Warned by FDA on Failure to Study Januvia Treatment for Side Effects and more... 2012-02-28 12:00 BioDelivery Sciences, FDA Reach Agreement On BNX Development Plan and more... 2012-02-28 00:00 Dendreon Posts 4th-Quarter Profit on Royalty Stream Sale, Provenge and more... 2012-02-27 12:00 Five Reasons Chelsea Therapeutics' Northera Will Get FDA Approval and more... 2012-02-25 12:00 GENFIT's drug candidate GFT505 gets patent protection from major countries and more... 2012-02-25 00:00 Pharmacyclics: When The Power Of A Pipeline Overshadows The Market's Influence On Value and more... 2012-02-24 12:00 How to Trade Dendreon Ahead of Earnings, and Other Biotechs to Watch and more... 2012-02-24 00:00 FDA panel recommends Chelsea Therapeutics drug and more... 2012-02-23 12:00 Chelsea Therapeutics: FDA Panel Live Blog and more... 2012-02-23 00:00 FDA panel overwhelmingly backs previously rejected anti-obesity pill Qnexa and more... 2012-02-22 12:00 Teva Pays $250M To Settle Propofol Lawsuits and more... 2012-02-22 00:00 J&J CEO Succession: Who is Alex Gorsky? and more... 2012-02-21 12:00 A Negative Vote for Vivus Obesity Drug, Says 'FDA Panel Whisperer' and more... 2012-02-21 00:00 After Gilead's Drop: Hedging 5 Biotechnology Stocks and more... 2012-02-20 00:00 5 Overlooked Healthcare Stocks To Consider Now 2012-02-19 12:00 Par Pharmaceutical Completes Acquisition of Edict Pharmaceuticals and more... 2012-02-19 00:00 Mylan Resolves Defamation Litigation Against Pittsburgh Post-Gazette and Two of Its Reporters and more... 2012-02-18 12:00 The Next DNA Disruptor? 2012-02-18 00:00 Pfizer grabs leg up in pursuit of rare disease drug win and more... 2012-02-17 12:00 Vivus obesity drug has safety risks-US FDA staff and more... 2012-02-17 00:00 J&JâÔö£é?öé??Ôö£é?ö?ñós Risperdal WasnâÔö£é?öé??Ôö£é?ö?ñót Factor in ManâÔö£é?öé??Ôö£é?ö?ñós Diabetes, Jury Rules and more... 2012-02-16 12:00 Alnylam climbs 16% on stock offer pricing and more... 2012-02-16 00:00 FDA biosimilars guidance sparks reviews of IP protection and more... 2012-02-15 12:00 Sun Pharma: Wyeth Claims Damages Of $960M In Protonix Case and more... 2012-02-15 00:00 Zalicus Says Workforce Reduction Is A Strategic Decision and more... 2012-02-14 12:00 5 High-Risk, High-Reward Biopharma Stocks and more... 2012-02-14 00:00 Regeneron climbs after raising Eylea sales outlook and more... 2012-02-13 12:00 BIO CEO Conference Live Blog and more... 2012-02-13 00:00 Expecting Gilead To Break $70, Outperforming Merck 2012-02-12 12:00 China Biotech Week in Review: Fosun Pharma Plans Large Hong Kong IPO and more... 2012-02-12 00:00 Mylan Intends to Challenge Unfavorable Verdict in Patent Trial Related to Mylan's Generic Version of Sunovion's Xopenex?ë?£... and more... 2012-02-11 12:00 FDA proposed guidelines open the door to biosimilars and more... 2012-02-10 12:00 [video] The Next Big Thing in Biotech: BIO CEO Conference and more... 2012-02-10 00:00 Glaxo Tests Cheaper Version of Advair for Emerging Markets and more... 2012-02-09 12:00 Cumberland Pharma shares rise on patent allowance and more... 2012-02-09 00:00 Seattle Genetics Inc. Fourth Quarter Earnings Sneak Peek and more... 2012-02-08 12:00 3 Biotech Companies Down But Not Out and more... 2012-02-08 00:00 Astex Falls Most Since 2004 as FDA Questions Drug and more... 2012-02-07 12:00 6 Drug Stocks Unworthy of Biotech Bull Market and more... 2012-02-07 00:00 Is the US Facing a Pharmaceutical Manufacturing Gap? and more... 2012-02-06 12:00 Neuralstem raises $5.2M in a registered direct offering and more... 2012-02-06 00:00 Compugen Jumps to 6-Year High in Tel Aviv on Cancer Treatment Technology and more... 2012-02-05 00:00 Lupin Limited: Buy and more... 2012-02-04 00:00 Abbott, Hospira Win Appellate Affirmation in Spinoff Retirement Lawsuit and more... 2012-02-03 12:00 Amgen risk/reward attractive into Xgeva panel, says Deutsche Bank and more... 2012-02-03 00:00 Are WuXi PharmaTech and ShangPharma M&A Targets? and more... 2012-02-02 12:00 FDA panel to discuss Arena obesity drug in 2nd quarter and more... 2012-02-02 00:00 Pfizer: Why It's All In The Pipeline and more... 2012-02-01 12:00 Dendreon And Provenge's True Median Life-Extension Benefit and more... 2012-02-01 00:00 Twitter Has Changed the News âÔö£é?öé??Ôö£é?ö?ç?ú What it Means for Pharma and more...   << Archive Index • Subscribe >>   Subscription preference center Archive Powered by FeedBlitz

Contact Us Past Issues Unsubscribe